Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib).
about
Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Abrogation of transforming gro ...... inhibitor SKI-606 (Bosutinib).
@en
Abrogation of transforming gro ...... osine kinase inhibitor SKI-606
@nl
type
label
Abrogation of transforming gro ...... inhibitor SKI-606 (Bosutinib).
@en
Abrogation of transforming gro ...... osine kinase inhibitor SKI-606
@nl
prefLabel
Abrogation of transforming gro ...... inhibitor SKI-606 (Bosutinib).
@en
Abrogation of transforming gro ...... osine kinase inhibitor SKI-606
@nl
P2860
P1433
P1476
Abrogation of transforming gro ...... inhibitor SKI-606 (Bosutinib).
@en
P2093
Peter J Wermuth
P2860
P304
P356
10.1371/JOURNAL.PONE.0196559
P407
P577
2018-05-02T00:00:00Z